Therapeutic use of infliximab in sight threatening uveitis: retrospective analysis of efficacy, safety, and limiting factors

被引：46

作者：

Bodaghi, B

Quoc, EB

Wechsler, B

Tran, THC

Cassoux, N

Huong, DLT

Chosidow, O

Herson, S

Piette, JC

LeHoang, P

机构：

[1] Univ Paris 06, Hop La Pitie Salpetriere, Dept Ophthalmol, F-75651 Paris, France

[2] Univ Paris 06, Hop La Pitie Salpetriere, Dept Internal Med, F-75651 Paris, France

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2005年 / 64卷 / 06期

关键词：

D O I：

10.1136/ard.2004.025882

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：962 / 964

页数：3

共 11 条

[1] Tumor necrosis factor antagonist therapy and lymphoma development - Twenty-six cases reported to the Food and Drug Administration [J].

Brown, SL ;

Greene, MH ;

Gershon, SK ;

Edwards, ET ;

Braun, MM .

ARTHRITIS AND RHEUMATISM, 2002, 46 (12) :3151-3158

[2] Anti-tumor necrosis factor-alpha therapy with infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen B27-associated acute anterior uveitis [J].

El-Shabrawi, Y ;

Hermann, J .

OPHTHALMOLOGY, 2002, 109 (12) :2342-2346

[3] Safety and efficacy of disease-modifying anti-rheumatic agents - Focus on the benefits and risks of etanercept [J].

Fleischmann, R ;

Iqbal, I ;

Nandeshwar, P ;

Quiceno, A .

DRUG SAFETY, 2002, 25 (03) :173-197

[4] Infliximab in the treatment of refractory posterior uveitis [J].

Joseph, A ;

Raj, D ;

Dua, HS ;

Powell, PT ;

Lanyon, PC ;

Powell, RJ .

OPHTHALMOLOGY, 2003, 110 (07) :1449-1453

[5]

Lim WS, 2002, NEW ENGL J MED, V346, P623

[6] Infliximab treatment of posterior uveitis [J].

Mansour, AM .

OPHTHALMOLOGY, 2004, 111 (01) :197-198

[7] Neutralizing tumor necrosis factor activity leads to remission in patients with refractory noninfectious posterior uveitis [J].

Murphy, CC ;

Greiner, K ;

Plskova, J ;

Duncan, L ;

Frost, A ;

Isaacs, JD ;

Rebello, P ;

Waldmann, H ;

Hale, G ;

Forrester, JV ;

Dick, AD .

ARCHIVES OF OPHTHALMOLOGY, 2004, 122 (06) :845-851

[8]

Rosenbaum JT, 2002, CLIN EXP RHEUMATOL, V20, pS143

[9] Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behcet disease [J].

Sfikakis, PP ;

Kaklamanis, PH ;

Elezoglou, A ;

Katsilambros, N ;

Theodossiadis, PG ;

Papaefthimiou, S ;

Markomichelakis, N .

ANNALS OF INTERNAL MEDICINE, 2004, 140 (05) :404-406

[10]

Smith JR, 2001, ARTHRIT RHEUM-ARTHR, V45, P252, DOI 10.1002/1529-0131(200106)45:3<252::AID-ART257>3.3.CO

← 1 2 →